If the solution remains clear, it has likely lost 1520% potency but may still provide partial research utility if no alternative is available
( Study of exercise-based rehabilitation for lumbar degenerative disc disease See PubMed .) Who Performs This Treatment
Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, Ettner R, Fraser L, Goodman M, Green J, Hancock AB, Johnson TW, Karasic DH, Knudson GA, Leibowitz SF, Meyer-Bahlburg HFL, Monstrey SJ, Motmans J, Nahata L, Nieder TO, et al
It did not
These findings are promising, but they do not prove that GlyNAC reverses aging, prevents age-related disease or extends life
Injectable peptides, on the other hand, face NONE of these molecular weight restrictions